WSR 17-04-065
[Filed January 30, 2017, 8:55 a.m.]
Original Notice.
Preproposal statement of inquiry was filed as WSR 15-17-041.
Title of Rule and Other Identifying Information: WAC 260-70-630 Thresholds.
Hearing Location(s): Auburn City Council Chambers, 25 West Main, Auburn, WA 98002, on March 10, 2017, at 9:30 a.m.
Date of Intended Adoption: March 10, 2017.
Submit Written Comments to: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516-5578, email, fax (360) 459-6461, by March 7, 2017.
Assistance for Persons with Disabilities: Contact Patty Brown, 6326 Martin Way, Suite 209, Olympia, WA 98516, or call TTY 711, by March 7, 2017.
Purpose of the Proposal and Its Anticipated Effects, Including Any Changes in Existing Rules: To update and add recommended thresholds by the Association of Racing Commissioners International to move toward uniformity from jurisdiction to jurisdiction.
Reasons Supporting Proposal: Uniformity would be beneficial to the industry from the standpoint that trainers would not be required to be educated on medication practices each time the [they] move to a new jurisdiction. Consistency would ensure horses are treated in the same way from state to state.
Statutory Authority for Adoption: RCW 67.16.020.
Rule is not necessitated by federal law, federal or state court decision.
Name of Proponent: [Horse racing commission], governmental.
Name of Agency Personnel Responsible for Drafting, Implementation, and Enforcement: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516-5578, (360) 459-6462.
No small business economic impact statement has been prepared under chapter 19.85 RCW. Not applicable.
A cost-benefit analysis is not required under RCW 34.05.328. Not applicable.
January 30, 2017
Douglas L. Moore
Executive Secretary
AMENDATORY SECTION (Amending WSR 15-13-079, filed 6/12/15, effective 7/13/15)
WAC 260-70-630 Threshold levels.
(1) Permitted medications.
(a) The following quantitative medications and/or metabolites are permissible in test samples up to the stated concentrations in urine:
Acepromazine - ((25)) 10 ng/ml
Albuterol - 1 ng/ml
Bupivicaine - 5 ng/ml
((Detomidine - 1 ng/ml))
Butorphanol - 300 ng/ml
Carboxydetomidine - 1 ng/ml
Mepivacaine - 10 ng/ml
((Omeprozole - 1 ng/ml))
Promazine - 25 ng/ml
Pyrilamine - 25 ng/ml
(b) The following quantitative medications and/or metabolites are permissible in test samples up to the stated concentrations in serum or plasma:
Betamethasone - 10 pg/ml
Butorphanol - 2 ng/ml
Clenbuterol - 25 pg/ml (in quarter horse and mixed breed races the presence of clenbuterol is prohibited)
Cetirizine - 6 ng/ml
Cimetidine - 400 ng/ml
Dantrolene - 100 pg/ml
Detomidine - 1 ng/ml
Dexamethasone - ((1)) .5 ng/ml
Diclofenac - 5 ng/ml
DMSO - 10 ((mc/ml)) mcg/ml
Firocoxib - 40 ng/ml
Glycopryrrolate - 3 pg/ml
Guaifenesin - 12 ng/ml
Isoflupredone - 100 pg/ml
Lidocaine - 20 pg/ml
Methocarbamol - 1 ng/ml
Methylprednisolone - ((1.3 ng/ml)) 400 pg/ml
Omeprazole - 10 ng/ml
Prednisolone - 1 ng/ml
*Procaine penicillin - 25 ng/ml
Ranitidine - 40 ng/ml
Triamcinolone acetonide - 100 pg/ml
Xylazine - ((0.2 ng/ml)) 200 pg/ml
Administration of procaine penicillin to those horses entered must be reported to the commission and may require surveillance up to six hours prior to post time.
(c) ((The official urine or blood test sample may not contain more than one of the above substances, including their metabolites or analogs, and may not exceed the concentrations established in this rule.)) Where a permitted medication has thresholds in both urine and serum or plasma, as set forth in this section, it is not a defense to a violation that the permitted medication does not exceed both thresholds.
(2) Environmental substances.
(a) Certain substances can be considered "environmental" in that they are endogenous to the horse or that they can arise from plants traditionally grazed or harvested as equine feed or are present in equine feed because of contamination or exposure during the cultivation, processing, treatment, storage, or transportation phases. Certain drugs are recognized as substances of human use and could therefore be found in a horse. The following substances are permissible in test samples up to the stated concentrations:
Arsenic - 0.3 ((mc/ml)) mcg/ml urine
Caffeine - 100 ng/ml serum or plasma
Cobalt - 50 ppb serum or plasma*
* A level of 25 ppb in serum or plasma will result in the horse being placed on the official veterinarians list until such time as the level drops below the 25 ppb.
Benzoylecgonine - 50 ng/ml urine
Estranediol - 0.045 ((mc/ml)) mcg/ml free + conjugated (5a-oestrane-3β,17a-diol), in the urine of male horses, other than geldings
Gamma Aminobutyric Acid (GABA) - 110 ng/ml in serum or plasma
Hydrocortisone - 1 ((mc/ml)) mcg/ml urine
Methoxytyramine - 4 ((mc/ml)) mcg/ml, free + conjugated urine
Morphine Glucuronides - 50 ng/ml urine
Salicylate ((saliclic)) salicylic acid - 750 ((mc/ml)) mcg/ml serum or plasma
Theobromine - 2 ((mc/ml)) mcg/ml urine
Tramadol - 50 ng/ml urine
(b) If a preponderance of evidence presented shows that a positive test is the result of environmental substance or inadvertent exposure due to human drug use, that evidence should be considered as a mitigating factor in any disciplinary action taken against the trainer.
(3) Androgenic-anabolic steroids.
(a) The following androgenic-anabolic steroids are permissible in test samples up to the stated concentrations:
Boldenone (Equipoise) - 15 ng/ml urine in intact males((. No level is permitted)) - 1 ng/ml in urine for geldings, fillies or mares.
Nandrolone (Durabolin) - 1 ng/ml urine in geldings, fillies, and mares, and for nandrolone metabolite (5a-oestrane-3β,17a-diol) - 45 ng/ml urine in intact males.
Testosterone - 20 ng/ml urine in geldings. 55 ng/ml urine in fillies and mares. Samples from intact males will not be tested for the presence of testosterone.
(b) All other androgenic-anabolic steroids are prohibited in race horses.